anti-viral

DRACO Flexible Anti-Viral Drug

Features: Current EventsCritical Path Innovation: BiologyInstitutions: MITFree Tagging: anti-viral
DRACO treatment of Rhinovirus and Dengue hemorrhagic fever

From MIT's Lincoln Laboratory comes a new drug called DRACO (Double-stranded RNA Activated Caspase Oligomerizers). Apparently DRACO is able to successfully treat 'nearly any viral infection'. This is accomplished because DRACO targets cells which have a type of RNA (double stranded RNA, dsRNA) which is only found in cells infected with a virus.

To date this anti-viral drug has been tested to be successful against 15 different types of viruses.


Syndicate content